Vivani Medical, Inc. (DE) Share Price
NASDAQ: VANI | Micro CapVivani Medical, Inc. (DE) Stock Performance
Open $1.40 | Prev. Close $1.41 | Circuit Range N/A |
Day Range $1.40 - $1.43 | Year Range $0.95 - $1.88 | Volume 1,759 |
Average Traded $1.41 |
Vivani Medical, Inc. (DE) Share Price Today
As of 29 August 2026, Vivani Medical, Inc. (DE)'s share price is $1.42. The stock opened at $1.40, compared to its previous close of $1.41. During today's trading session, Vivani Medical, Inc. (DE)'s share price traded between $1.40 and $1.43, with an average price of $1.41. Over the past 52 weeks, the stock has recorded a high of $1.88 and a low of $0.95. In terms of performance, Vivani Medical, Inc. (DE)'s share price has risen by 15.45% over the last six months and is up 21.89% on a year-on-year basis.
Vivani Medical, Inc. (DE) Share Price Chart
Vivani Medical, Inc. (DE) Stock Fundamentals & Key Indicators
Market Cap $88.59M | PE Ratio (TTM) -3.30 | Dividend Yield N/A |
EPS (TTM) $-0.43 | Revenue (TTM) N/A | Return On Equity (TTM) -169.16% |
Profit Margin N/A | Debt to Equity 0.42 | Quarterly Earnings Growth YoY -8.09% |
Vivani Medical, Inc. (DE) Quarterly Profit & Loss
All figures in USD
Vivani Medical, Inc. (DE) Annual Profit & Loss
All figures in USD
About Vivani Medical, Inc. (DE)
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature and subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant for metabolic diseases in cats. The company is headquartered in Alameda, California.
Vivani Medical, Inc. (DE) Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.29 | $1.40 | +8.56% |
Jul 2026 | $1.23 | $1.28 | +3.63% |
Jun 2026 | $1.33 | $1.24 | -6.42% |
May 2026 | $1.36 | $1.32 | -2.57% |
Apr 2026 | $1.02 | $1.36 | +33.33% |
Mar 2026 | $1.21 | $1.02 | -17.07% |
Feb 2026 | $1.42 | $1.23 | -11.83% |
Jan 2026 | $1.23 | $1.40 | +17.23% |
Dec 2025 | $1.34 | $1.19 | -13.45% |
Nov 2025 | $1.60 | $1.38 | -15.12% |
Oct 2025 | $1.44 | $1.62 | +12.50% |
Sep 2025 | $1.17 | $1.44 | +23.61% |